2016
DOI: 10.1684/ejd.2015.2667
|View full text |Cite
|
Sign up to set email alerts
|

Infantile linear IgA/IgG bullous dermatosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…Recently, immunoblot studies have indicated that LAGBD sera show circulating IgA and IgG antibodies reactive with various autoantigens: BP230, BP180 NC16a domain, 97/120‐kDa LAD‐1, BP180 C‐terminal domains, laminin‐332, 290‐kDa type‐VII collagen and 200‐kDa laminin‐γ1 . Our patient showed that IgG antibodies reacted with the BP180 NC16a domain and 120‐kDa LAD‐1 in immunoblotting analyses, and IgG antibodies to BP230 in ELISA.…”
Section: Discussionmentioning
confidence: 52%
See 1 more Smart Citation
“…Recently, immunoblot studies have indicated that LAGBD sera show circulating IgA and IgG antibodies reactive with various autoantigens: BP230, BP180 NC16a domain, 97/120‐kDa LAD‐1, BP180 C‐terminal domains, laminin‐332, 290‐kDa type‐VII collagen and 200‐kDa laminin‐γ1 . Our patient showed that IgG antibodies reacted with the BP180 NC16a domain and 120‐kDa LAD‐1 in immunoblotting analyses, and IgG antibodies to BP230 in ELISA.…”
Section: Discussionmentioning
confidence: 52%
“…Patients with LAGBD have responded well to DDS therapy in the same manner as that for LABD treatment . DDS has efficacy against skin diseases characterized by neutrophil‐rich infiltrates.…”
Section: Discussionmentioning
confidence: 99%
“…1,3 An immunological overlap spanning the clinical and immunologic spectrum between BP and LABD has been reported and referred to as linear IgA/IgG bullous dermatosis (LAGBD). 3,4 LAGBD has a unique clinical presentation, immunologic properties, and distinct therapeutic options 1,[5][6][7] including rituximab.…”
Section: Introductionmentioning
confidence: 99%